From the Journals
From the Journals
Alopecia tied to a threefold increased risk for dementia
“AA shares a similar inflammatory signature with dementia and has great psychological impacts that lead to poor social engagement,” lead author Dr...
From the Journals
Skin checks reduce all-cause but not melanoma-specific deaths
Routine skin checks, a surrogate for skin-cancer screening, did not outperform patient self-examination at detecting lesions.
From the Journals
Hair follicle miniaturization common in persistent chemo-induced alopecia, case series suggests
Defined as absent or incomplete hair regrowth 6 months or more after completion of chemotherapy, pCIA has been increasingly reported in the...
From the Journals
Immediate release of patient test results may have unintended consequences
“We’re learning that the majority of patients want to receive their results without delay, even if that means getting them before their health...
From the Journals
Sunscreen, other sun-protective habits not linked with poorer bone health, fractures
“These data are very reassuring and will help clinicians to keep recommending sun protection to the public.”
From the Journals
Coronavirus found to infect fat cells
“Infection of fat cells led to a marked inflammatory response, consistent with the type of immune response that is seen in severe cases of COVID-...
From the Journals
Higher odds for preterm, C-section births seen in women with PsA
Pregnant women with psoriatic arthritis may have an increased risk for preterm birth or cesarean delivery if they are receiving antirheumatic...
From the Journals
Some diuretics tied to increased skin cancer risk
Long-term use of hydrochlorothiazide was associated with a twofold increased risk of squamous cell carcinoma, compared with calcium channel...
From the Journals
Uncertainty looms large in treatment options for high-risk cutaneous SCC
More data – and high-quality data – are needed for physicians to determine with more confidence which adjuvant therapies would be best for...
From the Journals
Immunocompromised people face highest risk of cutaneous SCC metastasis
Immunocompromised individuals, such as solid organ transplant patients, make up 73.3% of all patients with cutaneous SCC who are at risk of...
From the Journals
Belimumab after rituximab a promising therapeutic strategy for lupus
Results of the phase 2b BEAT-LUPUS trial “suggest that this combination could be developed as a therapeutic strategy.”